pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
birelentinib
Refractory Chronic Lymphocytic Leukemia (CLL)
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 2
bisantrene
Zantrene (bisantrene)
Refractory Acute Myeloid Leukemia
Alpha-ketoglutarate-dependent dioxygenase FTO
Racura Oncology Ltd
0 catalysts
Phase 2
bitopertin
Anemia
Sodium- and chloride-dependent glycine transporter 1
Disc Medicine, Inc.
← prev
page 34 of 53
next →
131
Pain89
Neurology1
$IRON
0 catalysts
Phase 2
bivamelagon
bivamelagon [INN]
Obesity
$RYTMRHYTHM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
bizaxofusp
bizaxofusp [INN]
Recurrent Glioblastoma Multiforme (GBM)
$MDNAFMedicenna Therapeutics Corp.
0 catalysts
Phase 2
bleximenib besylate
Refractory Acute Myeloid Leukemia
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
bocunebart
bocunebart [INN]
Migraine
H. Lundbeck AS
0 catalysts
Phase 2
bosakitug
bosakitug [INN]
Atopic Dermatitis (Atopic Eczema)
$ACRSAclaris Therapeutics, Inc.
0 catalysts
Phase 2
botensilimab
Metastatic Colorectal Cancer
$AGENAGENUS INC
0 catalysts
Phase 2
botulinum vaccine [serogroups A, A1, B and B1]
Botulism
U.S. Army Medical Research Institute of Infectious Diseases
0 catalysts
Phase 2
brexucabtagene autoleucel
Tecartus (brexucabtagene autoleucel)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
B-lymphocyte antigen CD19
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 2
brilacidin
Chemotherapy Induced Oral Mucositis
Innovation Pharmaceuticals Inc
0 catalysts
Phase 2
briquilimab
Chronic Urticaria
Mast/stem cell growth factor receptor Kit
$JSPRJasper Therapeutics, Inc.
0 catalysts
Phase 2
brogidirsen
Duchenne Muscular Dystrophy
Nippon Shinyaku Co Ltd
0 catalysts
Phase 2
budoprutug
budoprutug [INN]
Membranous Glomerulonephritis
$CLYMClimb Bio, Inc.
0 catalysts
Phase 2
buloxibutid sodium
Idiopathic Pulmonary Fibrosis
Vicore Pharma AB
0 catalysts
Phase 2
bulumtatug fuvedotin
bulumtatug fuvedotin [INN]
Esophageal Squamous Cell Carcinoma (ESCC)
Mabwell Shanghai Bioscience Co Ltd
0 catalysts
Phase 2
bupropion
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
Bioron Pharma
0 catalysts
Phase 2
cabiralizumab
cabiralizumab [INN]
Pigmented Villonodular Synovitis
Bristol-Myers Squibb Co
0 catalysts
Phase 2
cafelkibart
cafelkibart [INN]
Solid Tumor
LaNova Medicines Ltd
0 catalysts
Phase 2
caffeine
Respiratory Depression (Hypoventilation)
Adenosine receptor
OYE Therapeutics Inc
0 catalysts
Phase 2
calpurbatug
calpurbatug [INN]
Prosthetic Joint infections
Trellis Bioscience Inc
0 catalysts
Phase 2
camonsertib
Solid Tumor
XenoTherapeutics Inc
0 catalysts
Phase 2
camupepimut
Colorectal Cancer
$ELTXElicio Therapeutics, Inc.
0 catalysts
Phase 2
canerpaturev
Metastatic Melanoma
Takara Bio Inc
0 catalysts
Phase 2
cannabidivarin
Autism Spectrum Disorder (ASD)
$JAZZJazz Pharmaceuticals plc
0 catalysts
Phase 2
canvuparatide hydrochloride
Hypoparathyroidism
$MBXMBX Biosciences, Inc.
0 catalysts
Phase 2
carbon monoxide
Sickle Cell Disease
Hillhurst Biopharmaceuticals Inc
0 catalysts
Phase 2
carotuximab
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endoglin
$KAPAKairos Pharma, LTD.
0 catalysts
Phase 2
casdozokitug
Hepatocellular Carcinoma
$CHRSCoherus Oncology, Inc.
0 catalysts